Table 3.
Variable | Non-obese group (n = 66) | Obese group (n = 66) | P |
---|---|---|---|
FBG (mg/dL) | 76.96 ± 6.98 | 84.65 ± 15.10 | < 0.001 |
HbA1c | 5.2 ± 0.26 | 5.4 ± 0.38 | < 0.001 |
Insulin (µIU/mL) | 7.77 ± 3.16 | 13.86 ± 4.88 | < 0.001 |
HOMA-IR | 1.03 ± 0.89 | 1.81 ± 1.44 | < 0.001 |
TC (mg/dL) | 134.53 ± 20.65 | 173.95 ± 35.44 | < 0.001 |
TG (mg/dL) | 112.16 ± 38.11 | 156.20 ± 64.53 | < 0.001 |
HDL-C (mg/dL) | 46.60 ± 9.31 | 37.18 ± 11.83 | < 0.001 |
LDL-C (mg/dL) | 69.69 ± 25.94 | 112.06 ± 33.92 | < 0.001 |
VLDL-C (mg/dL) | 22.44 ± 7.61 | 31.73 ± 12.86 | < 0.001 |
TC/HDL-C | 3.00 ± 0.78 | 5.27 ± 2.42 | < 0.001 |
TG/HDL-C | 2.52 ± 1.09 | 4.92 ± 3.73 | < 0.001 |
LDL-C/HDL-C | 1.56 ± 0.70 | 3.29 ± 1.93 | < 0.001 |
Atherogenic index | 2.00 ± 0.78 | 4.27 ± 2.42 | < 0.001 |
BDNF (ng/mL) | 84.27 ± 9.90 | 63.79 ± 17.44 | < 0.001 |
Values are presented as mean± standard deviation. The mean difference between the groups were analyzed using unpaired t-test. A P-value < 0.05 considered statistically significant.
FBG, fasting blood glucose; HbA1c, glycated hemoglobin; HOMA-IR, homeostatic model assessment of insulin resistance; TC, total cholesterol; TG, triglycerides; HDL-C, highdensity lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; VLDL-C, very low-density lipoprotein cholesterol; BDNF, brain derived neurotrophic factor.